Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients

被引:0
|
作者
Socha, J. [1 ]
Kepka, L. [2 ]
Ghosh, S. [3 ]
Roa, W. [3 ]
Kumar, N. [4 ]
Sinaika, V. [5 ]
Matiello, J. [6 ]
Lomidze, D. [7 ]
De Castro, D. Guedes [8 ]
Hentati, D. [9 ]
Fidarova, E. [10 ]
机构
[1] Reg Oncol Ctr Czestochowa, Radiotherapy, Czestochowa, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Radiotherapy, Warsaw, Poland
[3] Univ Alberta, Alberta Hlth Serv Canc, Radiotherapy, Edmonton, AB, Canada
[4] Post Grad Inst Med Educ & Res PGIMER, Radiotherapy & Oncol, Chandigarh, India
[5] NN Alexandrov Natl Canc Ctr Belarus, Radiotherapy, Minsk, BELARUS
[6] Irmandade Santa Casa Misericordia Porto Alegre, Radiotherapy, Porto Alegre, RS, Brazil
[7] Univ Clin, High Technol Med Ctr, Radiotherapy, Tibilisi, GA USA
[8] AC Camargo Hosp, Radiotherapy, Sao Paulo, Brazil
[9] Inst Natl Canc Salah Azaiz, Radiotherapy, Tunis, Tunisia
[10] IAEA, Appl Radiat Biol & Radiotherapy Sect, Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-0811
引用
收藏
页码:S407 / S408
页数:2
相关论文
共 50 条
  • [31] Being old is no fun: treatment of glioblastoma multiforme in the elderly
    Antonio, E.
    JOURNAL OF NEUROSURGERY, 2008, 108 (04) : 639 - 640
  • [32] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    Schiff, David
    Purow, Benjamin
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (04): : 186 - 187
  • [33] Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme
    David Schiff
    Benjamin Purow
    Nature Clinical Practice Oncology, 2008, 5 : 186 - 187
  • [34] Gefitinib and rapamycin for adult patients with recurrent glioblastoma multiforme
    Badruddoja, Michael A.
    Das, Asha
    Chu, Ray M.
    Gabyan, Eli
    Trimm, Heather
    Trycieky, Diane
    Yu, John
    Hurwitz, Carol
    Black, Keith L.
    NEURO-ONCOLOGY, 2006, 8 (04) : 438 - 438
  • [35] Bevacizumab and irinotecan in patients with recurrent glioblastoma multiforme (GBM)
    Raval, Sumul N.
    Rule, Amy
    Hwang, Shirley S.
    NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [36] Increased Expression of GRP78 Correlates with Adverse Outcome in Recurrent Glioblastoma Multiforme Patients
    Wen, Xue
    Chen, Xuan
    Cheng, Xiaoping
    TURKISH NEUROSURGERY, 2020, 30 (01) : 11 - 16
  • [37] Treatment outcome and prognostic factors of adult glioblastoma multiforme
    Ahmadloo, Niloofar
    Kani, Amir-Abbas
    Mohammadianpanah, Mohammad
    Nasrolahi, Hamid
    Omidvari, Shapour
    Mosalaei, Ahmad
    Ansari, Mansour
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (01) : 21 - 30
  • [38] Reoperation for Recurrent Glioblastoma Multiforme
    Robin, Adam M.
    Lee, Ian
    Kalkanis, Steven N.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2017, 28 (03) : 407 - +
  • [39] Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients
    Clarke, James W.
    Chang, Eric L.
    Levin, Victor A.
    Mayr, Nina A.
    Hong, Eugene
    Cavaliere, Robert
    Lo, Simon S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 733 - 741
  • [40] Bevacizumab in recurrent glioblastoma multiforme
    Tayah, Tania
    Ashrafieh
    Chahine, Georges Y.
    Kamar, Francois G.
    NEUROLOGY, 2008, 70 (11) : A296 - A297